BlackRock, Inc. 13D and 13G filings for Quest Diagnostics Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Quest Diagnostics Incorporated DGX |
BlackRock Inc. BLK |
9,308,815 8.400% |
-1,269,210 (-12.00%) |
Filing |
| 2024-01-24 5:23 pm Sale |
2023-12-31 | 13G | Quest Diagnostics Incorporated DGX |
BlackRock Inc. BLK |
10,578,025 9.400% |
-1,813,302 (-14.63%) |
Filing |
| 2023-01-23 3:52 pm Sale |
2022-12-31 | 13G | Quest Diagnostics Incorporated DGX |
BlackRock Inc. BLK |
12,391,327 10.900% |
-416,297 (-3.25%) |
Filing |
| 2022-04-08 09:57 am Purchase |
2022-03-31 | 13G | Quest Diagnostics Incorporated DGX |
BlackRock Inc. BLK |
12,807,624 10.700% |
1,171,242 (+10.07%) |
Filing |
| 2022-02-07 4:40 pm Purchase |
2021-12-31 | 13G | Quest Diagnostics Incorporated DGX |
BlackRock Inc. BLK |
11,636,382 9.500% |
172,167 (+1.50%) |
Filing |
| 2021-02-01 08:23 am Sale |
2020-12-31 | 13G | Quest Diagnostics Incorporated DGX |
BlackRock Inc. BLK |
11,464,215 8.500% |
-1,629,390 (-12.44%) |
Filing |